Mechanistic Studies of MDM2-mediated Ubiquitination in p53 Regulation
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
As a central regulator for cell cycle arrest, apoptosis, and cellular senescence, p53 requires multiple layers of regulatory control to ensure correct temporal and spatial functions. It is well accepted that Mdm2-mediated ubiquitination plays a crucial role in p53 regulation. In addition to proteasome-mediated degradation, ubiquitination of p53 by Mdm2 acts a key signal for its nuclear export. Nuclear export has previously been thought to require the disassociation of the p53 tetramer and exposure of the intrinsic nuclear export signal. To elucidate the molecular mechanism of degradation-independent repression on p53 by Mdm2, we have developed a two-step approach to purify ubiquitinated forms of p53 induced by Mdm2 from human cells. Surprisingly, however, we found that ubiquitination has no effect on the tetramerization/oligomerization of p53, arguing against this seemingly well accepted model. Moreover, nuclear export of p53 alone is not sufficient to completely abolish p53 activity. Ubiquitination-mediated repression of p53 by Mdm2 acts at least, in part, through inhibiting the sequence-specific DNA binding activity. Thus, our results have important implications regarding the mechanisms by which Mdm2 acts on p53.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
p53 ubiquitination: Mdm2 and beyond
Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924
Self-citationInteraction of Human DNA Polymerase η with Monoubiquitinated PCNA
Kannouche, P. L., Wing, J., & Lehmann, A. R. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00259-x · Cited by 845
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804
Self-citationMitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex
Leu, J. I.-J., Dumont, P., Hafey, M., Murphy, M. E., & George, D. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1123 · Cited by 770
Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Watanabe, K., Tateishi, S., Kawasuji, M., Tsurimoto, T., Inoue, H., & Yamaizumi, M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600383 · Cited by 538
Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation
Stommel, J. M., & Wahl, G. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600145 · Cited by 386
Research works printed but not linked: 36
- Vogelstein, 2000, Nature, 408, 307, 10.1038/35042675 · DOI · Paper page
- Caron de Fromentel, 1992, Genes Chromosomes Cancer, 4, 1, 10.1002/gcc.2870040102 · DOI · Paper page
- Greenblatt, 1994, Cancer Res., 54, 4855
- Laney, 1999, Cell, 97, 427, 10.1016/S0092-8674(00)80752-7 · DOI · Paper page
- Sigismund, 2004, Curr. Top. Microbiol. Immunol., 286, 149
- Mihara, 2003, Mol. Cell, 11, 577, 10.1016/S1097-2765(03)00050-9 · DOI · Paper page
- Xirodimas, 2001, Exp. Cell Res., 270, 66, 10.1006/excr.2001.5314 · DOI
- Gu, 1997, Cell, 90, 595, 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
- Weinmann, 2001, Mol. Cell. Biol., 21, 6820, 10.1128/MCB.21.20.6820-6832.2001 · DOI · Paper page
- Friedman, 1993, Proc. Natl. Acad. Sci. U. S. A., 90, 3319, 10.1073/pnas.90.8.3319 · DOI · Paper page
- Terrell, 1998, Mol. Cell, 1, 193, 10.1016/S1097-2765(00)80020-9 · DOI · Paper page
- Lohrum, 2001, Mol. Cell. Biol., 21, 8521, 10.1128/MCB.21.24.8521-8532.2001 · DOI · Paper page
- Nakamura, 2000, Mol. Cell. Biol., 20, 9391, 10.1128/MCB.20.24.9391-9398.2000 · DOI · Paper page
- Rodriguez, 2000, Mol. Cell. Biol., 20, 8458, 10.1128/MCB.20.22.8458-8467.2000 · DOI · Paper page
- Le Cam, 2006, Cell, 127, 775, 10.1016/j.cell.2006.09.031 · DOI · Paper page
- el-Deiry, 1993, Cell, 75, 817, 10.1016/0092-8674(93)90500-P · DOI · Paper page
- Luo, 2004, Proc. Natl. Acad. Sci. U. S. A., 101, 2259, 10.1073/pnas.0308762101 · DOI · Paper page
- Roth, 1998, EMBO J., 17, 554, 10.1093/emboj/17.2.554 · DOI · Paper page
- Middeler, 1997, Oncogene, 14, 1407, 10.1038/sj.onc.1200949 · DOI
- Boyd, 2000, Nat. Cell Biol., 2, 563, 10.1038/35023500 · DOI · Paper page
- Geyer, 2000, Nat. Cell Biol., 2, 569, 10.1038/35023507 · DOI · Paper page
- Kau, 2004, Nat. Rev. Cancer, 4, 106, 10.1038/nrc1274 · DOI · Paper page
- Freedman, 1999, Cell Mol. Life Sci, 55, 96, 10.1007/s000180050273 · DOI · Paper page
- Zhang, 2001, Cell Growth & Differ., 12, 175
- Carter, 2007, Nat. Cell Biol, 9, 428, 10.1038/ncb1562 · DOI · Paper page
- Arva, 2005, J. Biol. Chem., 280, 26776, 10.1074/jbc.M505203200 · DOI · Paper page
- White, 2006, Cancer Res., 66, 3463, 10.1158/0008-5472.CAN-05-1381 · DOI · Paper page
- Ohkubo, 2006, J. Biol. Chem., 281, 16943, 10.1074/jbc.M601388200 · DOI · Paper page
- Hicke, 2001, Nat. Rev. Mol. Cell Biol., 2, 195, 10.1038/35056583 · DOI · Paper page
- Sun, 2004, Curr. Opin. Cell Biol., 16, 119, 10.1016/j.ceb.2004.02.005 · DOI · Paper page
- Hoege, 2002, Nature, 419, 135, 10.1038/nature00991 · DOI · Paper page
- van der Horst, 2006, Nat. Cell Biol., 8, 1064, 10.1038/ncb1469 · DOI · Paper page
- Pickart, 2001, Annu. Rev. Biochem., 70, 503, 10.1146/annurev.biochem.70.1.503 · DOI · Paper page
- Chen, 2005, Cell, 121, 1071, 10.1016/j.cell.2005.03.037 · DOI · Paper page
- Dornan, 2004, Nature, 429, 86, 10.1038/nature02514 · DOI · Paper page
- Leng, 2003, Cell, 112, 779, 10.1016/S0092-8674(03)00193-4 · DOI · Paper page
Cited by
Role of p53 in Cell Death and Human Cancers
Ozaki, T., & Nakagawara, A. (2011) · Cancers · doi:10.3390/cancers3010994 · Cited by 650
p53 Acetylation: Regulation and Consequences
Reed, S., & Quelle, D. (2014) · Cancers · doi:10.3390/cancers7010030 · Cited by 332
The multiple levels of regulation by p53 ubiquitination
Lee, J. T., & Gu, W. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.77 · Cited by 289
Self-citationThe intricate role of growth hormone in metabolism
Vijayakumar, A., Yakar, S., & LeRoith, D. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00032 · Cited by 179
Yakovlev, V. A., Bayden, A. S., Graves, P. R., Kellogg, G. E., & Mikkelsen, R. B. (2010) · Biochemistry · doi:10.1021/bi100564w · Cited by 56
“The reason for the multiple bands at protein sizes corresponding to dimers and tetramers and observed by all investigators using glutaraldehyde to crosslink p53 is not known (24,25,39).”
Background
Metadata
- Authors
- Brooks, C. L., Li, M., & Gu, W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 282
- Issue
- 31
- Pages
- 22804-22815
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2044230130
- Cited by
- 48
- References
- 13
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4800 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.